| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.8M | +11.6% |
| Cost of Revenue | $6.1M | +15.3% |
| Gross Profit | -$1.3M | -31.2% |
| R&D Expense | $951K | -3.3% |
| SG&A Expense | $9.7M | -12.1% |
| Operating Income | -$29.0M | +13.0% |
| Interest Expense | $821K | +120.6% |
| Pre-tax Income | -$35.7M | +4.6% |
| Net Income | -$32.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $706K | -81.4% |
| Short-term Investments | $0 | — |
| Accounts Receivable | $239K | -29.0% |
| Inventory | $405K | +280.6% |
| Current Assets | $1.5M | -66.9% |
| Total Assets | $4.8M | -47.5% |
| Current Liabilities | $15.2M | +180.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.8M | +18.1% |
| Capital Expenditures | $212K | +121.2% |
| Investing Cash Flow | $373K | +131.9% |
| Financing Cash Flow | $13.4M | -23.9% |
| Free Cash Flow | -$17.0M | +17.4% |
| +13.6% |
| EPS (Basic) | -$1.66 | +44.3% |
| EPS (Diluted) | -$1.60 | +53.5% |
| Total Liabilities |
| $17.3M |
| +215.8% |
| Stockholders' Equity | -$11.8M | -750.3% |